Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units

被引:37
作者
Flournoy, DJ [1 ]
Reinert, RL [1 ]
Bell-Dixon, C [1 ]
Gentry, CA [1 ]
机构
[1] Vet Affairs Med Ctr, Pathol & Lab Med Serv, Oklahoma City, OK 73104 USA
关键词
D O I
10.1067/mic.2000.103836
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: We investigated gram-negative bacilli from patients in intensive care units to determine whether antimicrobial resistance was increasing Methods: Minimal inhibitory concentrations were determined by broth microdilution on 334 gram-negative bacilli collected in 1990, 1995, and 1998. Results: During the 3 study years, the types of gram-negative bacilli encountered in our intensive care units changed with proportional increases of Pseudomonas sp and decreases of inducible enterics. Dramatic increases in resistance for ceftazidime. cefotaxime, and piperacillin were paralleled between respiratory-tract isolates and inducible enterics. By 1998, ticarcillin was more active than piperacillin against most isolates except Escherichia coli and Klebsiella sp, and most isolates became more resistant to gentamicin and tobramycin. Conclusions: Continuous changes in the types of gram-negative bacilli and antimicrobial resistance complicate empirical selection of antimicrobials in the intensive care units. These complications will place more emphasis on communication and strategy formations among health care workers (nurses, physicians, laboratorians, and pharmacists) in an effort to treat infections in a timely and effective manner.
引用
收藏
页码:244 / 250
页数:7
相关论文
共 23 条
[1]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[2]  
BALLOW CH, 1992, DIAGN MICR INFEC DIS, V15, pS37
[3]   NATIONAL SURVEY OF THE IN-VITRO SPECTRUM OF PIPERACILLIN-TAZOBACTAM TESTED AGAINST MORE THAN 40,000 AEROBIC CLINICAL ISOLATES FROM 236 MEDICAL-CENTERS [J].
BARON, EJ ;
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (03) :141-151
[4]   Antibiotic resistance among gram-negative nosocomial pathogens in the intensive care unit: Results of 6-year body-site monitoring [J].
Barsic, B ;
Beus, I ;
Marton, E ;
Himbele, J ;
Kuzmanovic, N ;
Bejuk, D ;
Boras, A ;
Klinar, I .
CLINICAL THERAPEUTICS, 1997, 19 (04) :691-700
[5]   DISSEMINATION IN 5 FRENCH HOSPITALS OF KLEBSIELLA-PNEUMONIAE SEROTYPE-K25 HARBORING A NEW TRANSFERABLE ENZYMATIC RESISTANCE TO 3RD GENERATION CEPHALOSPORINS AND AZTREONAM [J].
BURE, A ;
LEGRAND, P ;
ARLET, G ;
JARLIER, V ;
PAUL, G ;
PHILIPPON, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (06) :780-782
[6]   CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES [J].
BURWEN, DR ;
BANERJEE, SN ;
GAYNES, RP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1622-1625
[7]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590
[8]   FACILITATING QUALITY-CONTROL OF THE ANTI-MICROBIAL SUSCEPTIBILITY TEST [J].
FLOURNOY, DJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1981, 13 (01) :231-232
[9]   A review of the role of antibiotic policies in the control of antibiotic resistance [J].
Gould, IM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :459-465
[10]   SHV-5, A NOVEL SHV-TYPE BETA-LACTAMASE THAT HYDROLYZES BROAD-SPECTRUM CEPHALOSPORINS AND MONOBACTAMS [J].
GUTMANN, L ;
FERRE, B ;
GOLDSTEIN, FW ;
PINTOSCHUSTER, E ;
ACAR, JF ;
COLLATZ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :951-956